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To the Editor: Epidemiological study has confirmed that women with a history of gestational diabetes mellitus (GDM) are at increased risk of developing type 2 diabetes mellitus later in life [1] . Women with a family history of diabetes also have a significantly increased risk of GDM [2] . Some researchers consider that GDM may share some risk factors and genetic susceptibility with type 2 diabetes mellitus. KCNQ1, located at chromosome 11p15.5, encodes the pore-forming K + channel alpha-subunit, which is produced in a wide variety of tissues including the pancreas. Recent evidence has revealed a strong association of KCNQ1 with susceptibility to type 2 diabetes [3, 4] . However, no studies have focused on the association between KCNQ1 gene polymorphism and GDM. Our aim in this study was to investigate the correlation between KCNQ1 variants and GDM in a Chinese population.
All pregnant women were screened for GDM between 24 and 28 weeks with a 50 g glucose challenge test (GCT). Plasma glucose 1 h after intake of glucose less than 7.8 mmol/l was defined as GCT negative (GCT−), but otherwise a participant was diagnosed as GCT positive (GCT+). GCT+ women then had a 100 g oral glucose tolerance test. The glucose threshold values were: fasting, 5.3 mmol/l; 1 h, 10.0 mmol/l; 2 h, 8.6 mmol/l; and 3 h, 7.8 mmol/l. If two or more of the glucose values met or exceeded the threshold value, GDM was diagnosed; normal glucose tolerance was diagnosed when all plasma glucose values were below the threshold values.
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Based on the above definitions, 1,436 pregnant women were included in the study: 520 with GDM; 275 who were GCT−; and 641 with normal glucose tolerance (the last two groups served as controls). Informed written consent was obtained from all participants, and the study was approved by the Institutional Review Board of our hospital.
Clinical and biochemical data of all participants, including age, blood pressure, plasma glucose, serum insulin, triacylglycerol and high-sensitivity C-reactive protein levels were collected at 24-28 weeks' gestation. The homeostasis model assessment (HOMA) index was calculated and used to assess beta cell function (HOMA-B) and insulin resistance (HOMA-IR). The details are presented in Electronic supplementary material (ESM) Table 1 .
KCNQ1 polymorphisms were genotyped by PCR and restriction fragment length polymorphism methods (ESM Tables 2 and 3 ). The statistical analyses were performed using SPSS 11.0 (SPSS, Chicago, IL, USA). Continuous data were analysed by t test or ANOVA. Non-parametric tests were performed when variables did not have a Gaussian distribution. The χ 2 test was used for comparisons between categorical variables. Bonferroni correction was used to correct for multiple testing. A two-sided p value <0.05 was considered statistically significant.
In order to calculate power, the following assumptions were made: a prevalence of GDM equal to 3%, a high-risk allele frequency of 0.15 and an effect size of 1.3. Under these assumptions, our sample of 520 cases and 916 controls would have >80% power with a type I error rate of 0.05. Power calculations were performed using the Genetic Power Calculator, available at http://ibgwww. colorado.edu/~pshaun/gpc/ (accessed 15 April 2009) [5] .
All .047], respectively), but the significance in the C allele disappeared after correcting for multiple testing (p c =0.083). The allele and genotype in SNP rs2237892 had no significant association with GDM (ESM Table 4 ).
Next, we investigated the association of the three SNPs with beta cell function and insulin resistance (ESM Table 5 ). Among all participants, the SNP rs2237895 variant was nominally associated with impairment of beta cell function, having a lower value for HOMA-B (p=0.021), but the significance was not seen after correcting for multiple testing (p c =0.062). Using the dominant model, the association was significant (p=0.005 [p c =0.016]) (HOMA-B was 140.25±142.15 [AC+CC] vs  158.15±99.66 [AA] ). However, we did not detect an association between the SNPs and insulin resistance based on HOMA.
In this study, our results were not entirely in accordance with previous studies on type 2 diabetes, in which the association of type 2 diabetes with three SNPs (rs2237892, rs2237895 and rs2237896) in KCNQ has been found to be strong (p<0.0001) [3, 4] . Here, we demonstrated that the SNP rs2237896 was the risk allele for GDM with moderate p values, the rs2237895 variant might predispose to GDM because of the diminished p c value, and we failed to show a statistical association between rs2237892 and GDM in a Chinese population. Given that our study was adequately powered, we believe these differences may be due to: (1) the diagnostic criteria and glucose threshold values adopted in our study; (2) the genetic background of our population and the heterogeneous nature of these disorders; (3) limited sample sizes; and (4) a smaller effect size (OR <1.3) of rs2237892.
In addition, we investigated the association of the three SNPs with beta cell function and insulin resistance using HOMA-B and HOMA-IR. Apart from a dominant model in rs2237895 variant, we did not find other genetic models associated with impairment of beta cell function after correcting the p value, but the homozygote of the risk allele had the lowest HOMA-B value, also suggesting beta cell dysfunction. Moreover, we did not detect any association between the SNPs and insulin resistance based on HOMA-IR values. Thus, we infer that KCNQ1 variants affect glucose metabolism, possibly through impairment of insulin secretion, in line with results from other studies in different populations [6, 7] .
In conclusion, our present study demonstrates a close link between SNPs in KCNQ1 and GDM. These effects may be through the impairment of beta cell function, but the precise mechanism remains unknown and further studies are needed for clarification.
